ArticleFrontiers in pharmacology2022

Association Between Obesity and Poor Prognosis in Patients Receiving Anlotinib for Advanced Non-Small Cell Lung Cancer.

Anning Xiong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.